| Product Code: ETC7918033 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Parkinsons Disease Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Parkinsons Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Parkinsons Disease Market - Industry Life Cycle |
3.4 Latvia Parkinsons Disease Market - Porter's Five Forces |
3.5 Latvia Parkinsons Disease Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Latvia Parkinsons Disease Market Revenues & Volume Share, By Medical Devices, 2021 & 2031F |
3.7 Latvia Parkinsons Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Latvia Parkinsons Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 Latvia Parkinsons Disease Market Revenues & Volume Share, By Patient Care Setting, 2021 & 2031F |
4 Latvia Parkinsons Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of Parkinson's disease in Latvia |
4.2.2 Rising awareness and diagnosis rates of Parkinson's disease |
4.2.3 Technological advancements in treatment options for Parkinson's disease |
4.3 Market Restraints |
4.3.1 High treatment costs associated with Parkinson's disease management |
4.3.2 Limited access to specialized healthcare services in certain regions of Latvia |
4.3.3 Regulatory challenges in drug approvals and market access for new treatments |
5 Latvia Parkinsons Disease Market Trends |
6 Latvia Parkinsons Disease Market, By Types |
6.1 Latvia Parkinsons Disease Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Latvia Parkinsons Disease Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Latvia Parkinsons Disease Market Revenues & Volume, By Levodopa/Carbidopa, 2021- 2031F |
6.1.4 Latvia Parkinsons Disease Market Revenues & Volume, By Dopamine Receptor Agonists, 2021- 2031F |
6.1.5 Latvia Parkinsons Disease Market Revenues & Volume, By MAO-Inhibitors, 2021- 2031F |
6.1.6 Latvia Parkinsons Disease Market Revenues & Volume, By COMT-Inhibitors, 2021- 2031F |
6.1.7 Latvia Parkinsons Disease Market Revenues & Volume, By Anticholinergics, 2021- 2031F |
6.1.8 Latvia Parkinsons Disease Market Revenues & Volume, By Other Drugs, 2021- 2031F |
6.2 Latvia Parkinsons Disease Market, By Medical Devices |
6.2.1 Overview and Analysis |
6.2.2 Latvia Parkinsons Disease Market Revenues & Volume, By Deep Brain Stimulation (DBS) Devices, 2021- 2031F |
6.2.3 Latvia Parkinsons Disease Market Revenues & Volume, By Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices, 2021- 2031F |
6.3 Latvia Parkinsons Disease Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Latvia Parkinsons Disease Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Latvia Parkinsons Disease Market Revenues & Volume, By Transdermal, 2021- 2031F |
6.3.4 Latvia Parkinsons Disease Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.5 Latvia Parkinsons Disease Market Revenues & Volume, By Intestinal Infusion, 2021- 2031F |
6.3.6 Latvia Parkinsons Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Latvia Parkinsons Disease Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Latvia Parkinsons Disease Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Latvia Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Latvia Parkinsons Disease Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.5 Latvia Parkinsons Disease Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.5 Latvia Parkinsons Disease Market, By Patient Care Setting |
6.5.1 Overview and Analysis |
6.5.2 Latvia Parkinsons Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Latvia Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
7 Latvia Parkinsons Disease Market Import-Export Trade Statistics |
7.1 Latvia Parkinsons Disease Market Export to Major Countries |
7.2 Latvia Parkinsons Disease Market Imports from Major Countries |
8 Latvia Parkinsons Disease Market Key Performance Indicators |
8.1 Average age of diagnosis of Parkinson's disease in Latvia |
8.2 Number of neurologists specialized in Parkinson's disease in Latvia |
8.3 Adoption rate of advanced treatment options for Parkinson's disease in Latvia |
8.4 Patient satisfaction with Parkinson's disease management services |
8.5 Rate of hospital readmissions for Parkinson's disease patients in Latvia |
9 Latvia Parkinsons Disease Market - Opportunity Assessment |
9.1 Latvia Parkinsons Disease Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Latvia Parkinsons Disease Market Opportunity Assessment, By Medical Devices, 2021 & 2031F |
9.3 Latvia Parkinsons Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Latvia Parkinsons Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 Latvia Parkinsons Disease Market Opportunity Assessment, By Patient Care Setting, 2021 & 2031F |
10 Latvia Parkinsons Disease Market - Competitive Landscape |
10.1 Latvia Parkinsons Disease Market Revenue Share, By Companies, 2024 |
10.2 Latvia Parkinsons Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here